
Adeel Nasrullah, MD
@adeel_nasrullah
Pulmintensivit 🫁@AHNtoday | Alumni @AHNIMRES @ShifaAlumni | Editorial Member @BMC_series| Interests=Obstructive Lung Diseases | Tweets are my own| 🇵🇰 🇺🇸
ID: 1132476354375634944
https://scholar.google.com/citations?hl=en&user=XQMWtmsAAAAJ&view_op=list_works&sortby=pubdate 26-05-2019 02:39:38
604 Tweet
835 Followers
232 Following


Thrilled to announce that our study on temporary Mechanical Circulatory Support (MCS) in AMI vs. HF cardiogenic shock has been published in Cardiovascular Revascularization Medicine. Grateful to the team for their hard work and collaboration! Laith Alhuneafat Abdallah Naser, MD American College of Cardiology




Honored to share our recent publication under the guidance of Abu Baker Sheikh, MD on inpatient outcomes for STEMI pts with and without a dx of OSA. link.springer.com/article/10.100… Here are the 🔑 findings:

Here Dr. Sadatsafavi UBC Pharm Sci and I make the argument that triple inhaled therapy be considered earlier in the course of #COPD and for most (if not all) patients. bit.ly/3Nh9W6j



Original Article: First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate (PREDMETH trial) nej.md/4kdaf0o Editorial: Methotrexate as Initial Therapy for Symptomatic Pulmonary Sarcoidosis? nej.md/4mhaHfW #ATS2025 | American Thoracic Society (ATS)
